Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Cardiotoxicity 8Osteosarcoma 5Recurrence 4Rhabdomyosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Leukemia 3Breast Neoplasms 3Sarcoma, Ewing 2Myelodysplastic Syndromes 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Ganglioneuroblastoma 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Blast Crisis 2Vomiting 1Unspecified Adult Solid Tumor, Protocol Specific 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Myeloid 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1PRETEXT I Hepatoblastoma 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 3Nutrition Assessment 3Exercise 3Carvedilol 3dapagliflozin 2Standard of Care 2Rituximab 2Ivabradine 2Control Groups 2Atorvastatin 2pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1acalabrutinib 1Vincristine 1Valsartan 1Trastuzumab 1Surveys and Questionnaires 1Spironolactone 1Sodium Chloride 1Simendan 1Secondary Prevention 1Resistance Training 1Pyruvic Acid 1Prednisolone 1Practice Guidelines as Topic 1Population Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Heart Failure × Dexrazoxane × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡